Core Viewpoint - The article highlights the evolution and achievements of Anhui Xinbo Aluminum Co., Ltd. (Xinbo) over 17 years, showcasing its transformation from a small aluminum factory to a publicly listed company with projected revenue exceeding 8 billion by 2025, emphasizing its role in the high-quality development of China's capital market [1][4][5]. Group 1: Company Evolution - Xinbo transitioned from a small aluminum factory to a major player in the aluminum industry, successfully shifting focus from construction aluminum to industrial aluminum profiles between 2007 and 2013, achieving over 70% market share in the domestic market for high-speed rail power transmission components [4]. - The company capitalized on the photovoltaic boom from 2017 to 2021, becoming a core supplier for leading firms like Longi Green Energy and JinkoSolar, and increased its annual production from 115,700 tons in 2021 to a projected 380,000 tons by 2024 [5]. - Since 2022, Xinbo has expanded into the electric vehicle parts market, providing critical components for major automotive brands, while also launching a 600,000-ton recycled aluminum project that reduces energy consumption by 95% [6]. Group 2: Financial Growth and Strategic Initiatives - Xinbo's IPO raised nearly 500 million, facilitating capacity expansion, and subsequent refinancing efforts raised 1.66 billion for further production and raw material integration [9]. - The company has established a unique welfare system, investing an average of 13,000 yuan per employee annually, and has implemented a "family culture" that significantly reduces employee turnover [8][9]. Group 3: Industry Leadership and Innovation - Xinbo has set industry standards for aluminum profiles, with its 6A05 alloy material achieving a tensile strength of 350 MPa, extending the lifespan of photovoltaic components to over 30 years [12]. - The company has expanded its international presence through subsidiaries in Vietnam and Malaysia, exporting photovoltaic aluminum frames to India and Southeast Asia [12][13]. - Xinbo is leading the shift from price competition to value co-creation in the aluminum industry, providing customized solutions to over 2,000 enterprises [13]. Group 4: Future Outlook - Looking towards 2025, Xinbo aims to enter the low-altitude economy and robotics sectors, leveraging its existing production lines and technology to develop high-performance aluminum components for these emerging markets [15]. - The company's growth trajectory reflects a commitment to strategic innovation and humanistic care, positioning it as a leader in the transition from traditional manufacturing to high-end intelligent manufacturing [16][17].

历经二十一载岁月沉淀，新财富金牌董秘评选已成为中国资本市场极具权威性与公信力的标杆评选，不仅见证 了中国资本市场蓬勃发展的壮阔征程，更以专业视角镌刻下时代变革的深刻印记。金牌董秘群体凭借卓越的专 业素养与创新实践能力，持续优化上市公司治理、深化投资者关系管理，已然成为推动中国资本市场向高质量 发展迈进的一股重要力量。 值此新财富董秘评选二十一周年之际，诚邀历届金牌董秘，分享企业战略、发展历程与职业经验，以实战洞见 解构资本风云，共探行业发展逻辑。 周震，1981年10月生，天津大学电子信息工程、工程管理专业，本科双学位，高级工程师。 职业生涯起步于中国电子科技集团公司第七研究所，曾担任规划发展部副主任、民品处副处长（主持 工作）。此后，担任广州市弘宇科技有限公司党支部书记、副总裁，移动通信国家工程研究中心副主 任。 0 1 双轨赋能：技术与资本双轮驱动的金牌董秘周震 技术+管理的双轨背景 兼具技术理解力与商业思维，契合科技型企业对董秘"既懂业务又懂资本"的复合要求。 从业务到资本的闭环能力 2017年10月取得深圳证券交易所董事会秘书任职资格证书。 2022年2月起，正式担任中电科普天科技股份有限公司（普天科 ...

Core Viewpoint - The article highlights the significance of the New Fortune Gold Medal Secretary selection in the Chinese capital market, emphasizing the role of outstanding secretaries in enhancing corporate governance and investor relations, thus contributing to high-quality market development [1]. Group 1: Company Overview - Kaineng Health has been focusing on its core water purification business while advancing a globalization strategy, optimizing product structure, and improving operational efficiency to achieve growth in scale, quality, and profitability [1][4]. - Xu Yanmao, the company secretary, has a strong investment banking background and plays a crucial role in connecting the capital market with corporate development [1][4]. Group 2: Governance Innovation - Xu Yanmao promotes a long-term value creation approach, establishing a stable, efficient, and transparent market value management system, thereby enhancing corporate governance [8]. - The governance structure has been improved through systematic enhancements of the "three meetings" process, ensuring compliance and efficiency in shareholder meetings, board meetings, and supervisory meetings [9]. - In response to regulatory changes, Xu led the revision of ten core systems, including ESG management and related party transaction decision-making, transitioning governance from reactive to proactive [9]. Group 3: Investor Relations - Xu demonstrates effective communication strategies by engaging with well-known sell-side institutions and organizing regular performance briefings, thereby accurately conveying the company's strategic value [10]. - The company has achieved modernization in governance and an increase in total market value, receiving multiple accolades such as "National Green Factory" and "Specialized and New Little Giant" [10]. Group 4: Capital Operations and Strategic Drive - Xu promotes a shift in market value management from a tool-based approach to a value-driven strategy, focusing on maximizing company value through systematic institutional development and capital project execution [12]. - The company is enhancing its capital structure through various mechanisms, including convertible bonds and shareholder return policies, becoming the first in its sector to implement special dividends post-dividend policy reform [12]. - Kaineng Health is expanding its dual-driven model of "water purification + cells," focusing on technological innovation and smart manufacturing while exploring opportunities in the health sector through its investment in Yuaneng Group [13]. Group 5: Globalization Efforts - The company is accelerating its global expansion, establishing a presence in over 100 countries and regions, and is recognized as one of the few Chinese water purification equipment companies with a global distribution network [15]. - The management team is committed to transforming Kaineng into a multinational corporation in the water purification industry through strategic capital operations and local production [15].

Core Viewpoint - The article highlights the significance of the role of a company secretary (董秘) in bridging the gap between the enterprise and the capital market, emphasizing their contribution to corporate governance and investor relations management, particularly in the context of the evolving Chinese capital market [1]. Group 1: Career Development of Liu Xinren - Liu Xinren, the company secretary of Jiahe Foods, transitioned from a procurement manager to a key figure in connecting the company with the capital market over two decades [3]. - His pivotal career moment occurred during the IPO preparation phase, where he led the team through the intense process of IPO application, culminating in Jiahe Foods' successful listing on the A-share market in April 2021 [4]. - Post-IPO, Liu's responsibilities shifted towards regulatory compliance, market capitalization management, and investor communication, earning him multiple accolades for his professional capabilities [5]. Group 2: Strategic Transformation of Jiahe Foods - Jiahe Foods, initially known for its plant-based creamers, faced challenges due to changing consumer preferences and competition, prompting a strategic pivot towards coffee as a new growth avenue [8]. - The company capitalized on the rising coffee consumption trend, increasing from 9 cups per person in 2022 to 16.74 cups in 2023, and had already invested in coffee production capabilities since 2017 [9]. - Liu spearheaded a significant capital operation, raising 725 million yuan through a private placement to expand coffee production capacity, which includes various coffee products [9][10]. Group 3: Role and Challenges of a Company Secretary - The role of a company secretary extends beyond mere compliance; it involves maintaining corporate stability and managing investor relations post-IPO [14]. - Liu emphasized the importance of managing expectations and effectively communicating the company's strategies and long-term value to investors, balancing transparency with strategic messaging [15]. - The company secretary acts as a central figure in coordinating communication among various stakeholders, ensuring that the company's interests are represented accurately [16][17]. Group 4: Conclusion on the Role of Company Secretaries - Liu's career trajectory exemplifies the evolving role of company secretaries as vital contributors to corporate governance and strategic decision-making, particularly in navigating complex capital market dynamics [19]. - The article underscores the need for company secretaries to possess a deep understanding of both regulatory frameworks and market conditions, positioning them as essential players in fostering trust and transparency between companies and investors [19].

0 1 专业赋能：财务法律复合背景，筑牢董秘技能根基 袁钢本科毕业于中南财经政法大学会计学专业，硕士毕业于北京大学法律硕士（财税法方向）专业， 财务与法律的双重知识体系，为他奠定了扎实的专业基础。毕业后，他在中国石化开启职业生涯，央 企的工作经历让他养成了规范的公司治理理念，锻炼出敏锐的行业研究能力和应对复杂问题的综合处 理能力。 财务与法律的双重专业背景以及在央企的工作经历，让他在面对复杂的资本市场环境时，能够与会计 师、律师、评估师等专业人士进行专业沟通与协作，特别是在涉及财务和法律交叉问题时，他能够结 合公司合法权益，更加全面地给出专业意见和建议；在公司定期报告与临时公告的编制与审核中，他 凭借扎实的财务专业知识，从公司业务、行业趋势的角度去解读财务数据，为投资者提供清晰、可 靠、易懂的公司经营情况和行业信息；在公司重大合同的签订与法律风险把控上，他运用所学法律知 识，在合同签订前确保合同条款的严谨性和公平性，在合同执行中根据最新情况及时采取措施，降低 法律风险，维护公司合法权益。这些宝贵的专业素养与职业能力，为袁钢日后在索通发展董秘岗位上 的卓越表现奠定了坚实基础。 历经二十一载岁月沉淀，新财富金牌董 ...

Core Viewpoint - The article discusses the implications of former President Trump's healthcare policies, particularly the "Most Favored Nations" (MFN) pricing strategy, which aims to lower U.S. drug prices by aligning them with the lowest prices in other countries. This policy has sparked significant investment from multinational pharmaceutical companies in U.S. manufacturing and R&D capabilities, indicating a major shift in the global pharmaceutical industry landscape [3][4]. Group 1: MFN Pricing Policy - The MFN pricing policy mandates that U.S. Medicare and Medicaid drug prices cannot exceed the lowest prices in other developed countries, directly targeting the high drug prices in the U.S. [6][9] - The policy has faced criticism from various stakeholders, including the pharmaceutical industry, which views it as a potential threat to profitability, especially for innovative drugs still in early commercialization stages [6][7][9]. - Despite the potential benefits of controlling healthcare costs, the policy is seen as a high-pressure tactic that may lead to significant adjustments in global pricing strategies by pharmaceutical companies [7][9]. Group 2: Investment Trends in U.S. Pharmaceutical Manufacturing - Major pharmaceutical companies, including Merck, Roche, Novartis, and Eli Lilly, have announced substantial investments in U.S. manufacturing and R&D, totaling hundreds of billions of dollars, in response to the changing policy landscape [4][12][13]. - These investments are not merely for capacity expansion but are strategic moves to adapt to anticipated policy changes, with companies aiming to enhance supply chain resilience and local production capabilities [12][13][16]. - The shift towards domestic manufacturing is also driven by concerns over the reliance on foreign supply chains, particularly for essential drugs and raw materials [16]. Group 3: Impact on Different Segments of the Pharmaceutical Industry - The healthcare and tariff policies under Trump's administration have created a bifurcation within the pharmaceutical industry, where some companies face cost pressures while others benefit from regulatory changes [18][24]. - Companies heavily reliant on Medicare payments, particularly those producing biosimilars and chronic disease medications, are expected to face significant challenges due to tightening Medicaid budgets and reduced insurance coverage [20][21]. - Conversely, innovative drug companies may benefit from the maintenance of pricing power and expedited FDA approval processes, allowing them to navigate the market more effectively [22][23][24]. Group 4: Overall Industry Dynamics - The article highlights a transformative period for the global pharmaceutical industry, characterized by a shift from a "global manufacturing + free pricing" model to a more localized and regulated approach [24]. - The pressures from new policies necessitate that pharmaceutical companies reassess their operational strategies, focusing on cost control, supply chain security, and adaptability to regulatory changes [24]. - The evolving landscape presents both opportunities and risks, with companies needing to find long-term strategies to thrive amid uncertainty [24].

Core Viewpoint - The article highlights the increasing accessibility and importance of trust services in wealth management, particularly through insurance trusts and family trusts, as depicted in the popular drama "Mán Hǎo de Rénshēng" [2][3][4]. Group 1: Trust Services Overview - Trust services, traditionally seen as exclusive to high-net-worth individuals, are becoming more accessible with new models like insurance trusts lowering entry barriers to around 1 million yuan [3][4]. - The trust industry in China has evolved significantly, with a historical backdrop that includes the establishment of the first trust company in 1921 and a resurgence in the 1980s [4][5]. - Recent regulatory changes have categorized trust services into three main types, emphasizing the growth of wealth management services, which have seen a compound annual growth rate of 37% over the past six years, surpassing 1 trillion yuan in scale [6][15]. Group 2: Company Case Study - Ping An Trust - Ping An Trust has adapted to industry changes by positioning wealth management services as a core strategic focus, achieving a scale of over 220 billion yuan in wealth management services, with insurance trusts accounting for 170 billion yuan [9][18]. - The "Hong Cheng Shi Jia" brand has been upgraded to encompass a broader range of wealth management services, including family trusts and charitable trusts, reflecting a comprehensive approach to meet diverse client needs [13][16]. - The insurance trust product line, particularly the "Hong Fu" series, has experienced rapid growth, with a compound growth rate of 39% and a market share exceeding 40% [18][19]. Group 3: Future Outlook and Strategic Initiatives - Ping An Trust plans to lower the entry threshold for pension trusts to below 1 million yuan to enhance accessibility and meet growing market demand [33]. - The company aims to strengthen its operational and technological capabilities to support the anticipated increase in business volume and client base [33][34]. - Future strategies include enhancing non-financial services related to health management and elder care, positioning trust services as a comprehensive solution for clients' long-term needs [35][36].

历经二十一载岁月沉淀，新财富金牌董秘评选已成为中国资本市场极具权威性与公信力的标杆评选，不仅见证 了中国资本市场蓬勃发展的壮阔征程，更以专业视角镌刻下时代变革的深刻印记。金牌董秘群体凭借卓越的专 业素养与创新实践能力，持续优化上市公司治理、深化投资者关系管理，已然成为推动中国资本市场向高质量 发展迈进的一股重要力量。 值此新财富董秘评选二十一周年之际，诚邀历届金牌董秘，分享企业战略、发展历程与职业经验，以实战洞见 解构资本风云，共探行业发展逻辑。 李旭女士，现任北京全时天地在线网络信息股份有限公司（002995）副总经理、董事会秘书，她于 2020年加入天地在线，负责公司合规治理、资本运作、投融资等工作。作为资本市场的重要桥梁，李 旭以其专业素养与战略眼光，推动天地在线在合规发展与资本运作的双重赛道上稳健前行。 0 1 "专业"铸就荣誉 在她个人的职业成长中，李旭深刻体会到董秘工作需兼具"广度"与"深度"— 既要精通财务、法律、金 融等专业知识，也要具备战略眼光与危机处理能力。每一次路演中的精准应答，每一份公告中的严谨 表述，每一场谈判中的价值坚守，都是对"专业"二字的践行。 多年深耕，李旭积累了深厚的业务理 ...

Core Viewpoint - The New Fortune Golden Secretary Award has become a benchmark in China's capital market, reflecting the development of the market and the importance of excellent secretaries in corporate governance and investor relations management [1] Group 1: Award Recognition - The 21st New Fortune Golden Secretary Award recognized Ms. Ye Jing from Yimikang as the "Golden Secretary" for her professional knowledge, rich experience, and keen market insight [2] Group 2: Company Performance - Yimikang achieved a revenue of 318 million yuan in Q1, representing a year-on-year growth of 26.44%, and a net profit of 7.04 million yuan, up 34.77% year-on-year [6] - The company has transitioned from a provider of precision air conditioning for data centers to a service provider of green solutions for the entire lifecycle of digital infrastructure [6] Group 3: Governance and Management - Ms. Ye has emphasized the importance of compliance and investor relations management since her appointment as the board secretary, enhancing the company's image in the capital market [4] - She has actively participated in the asset divestiture plan, ensuring alignment with the company's strategy and safeguarding its interests [7] Group 4: Strategic Focus - Yimikang is focusing on the information data sector, with a goal to become a leading enterprise in China's digital infrastructure field, leveraging technological innovation and customer demand [11] - The company aims to integrate its strengths across various segments, including temperature control equipment, intelligent engineering, IoT software, and smart services, to create efficient and green digital infrastructure [11]

Core Viewpoint - The article highlights the significance of the "Golden Secretary" award in the Chinese capital market, emphasizing the role of outstanding secretaries in enhancing corporate governance and investor relations, thus contributing to the high-quality development of the market [1]. Group 1: Capital Strategy and Operations - Chang Yang, the Secretary of the Board at Jinko Power Technology Co., Ltd., has played a crucial role in the company's capital market operations and compliance system since joining in 2021, focusing on "concentration" and "professionalism" as key strategies to navigate industry uncertainties [3][4]. - Under Chang's leadership, Jinko Power successfully issued a 500 million yuan green corporate bond in May 2022, marking a significant milestone in the capital market and showcasing its demonstration effect within the industry [4]. - Chang's strategic timing in capital operations, such as the 3 billion yuan private placement approved by the CSRC at the end of 2022, allowed the company to raise funds effectively during a challenging market environment, enhancing its shareholder structure and market image [6]. Group 2: Financial Performance - In 2023, Jinko Power reported a revenue of 4.37 billion yuan, a year-on-year increase of 36.72%, and a net profit attributable to shareholders of 383 million yuan, reflecting a substantial growth of 77.05% [6]. Group 3: Corporate Governance and Compliance - Chang Yang positions himself as a "value transmitter with rigor," emphasizing compliance as a core responsibility of the Secretary of the Board, ensuring the company's operational management is safeguarded through professional oversight [8]. - The company aims to create a transparent and well-structured governance framework, focusing on clear asset management and effective communication with various stakeholders, including regulators and investors [9]. Group 4: Strategic Choices and Diversification - Jinko Power is transitioning towards a light asset operation model while diversifying its business layout, focusing on green electricity operations and leveraging its project development resources [11][13]. - The company has successfully established a healthy turnover model for its assets, enhancing its resilience against market fluctuations and positioning itself for future growth opportunities in various renewable energy applications [13][14].